PREPROPOSAL STATEMENT OF INQUIRY
(Board of Pharmacy)
Subject of Possible Rule Making: Chapter 246-887 WAC, regulations implementing the Uniform Controlled Substances Act. Placement of the substance, carisoprodol, in schedule IV of the Uniform Controlled Substances Act.
Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 18.64.005(7), 69.50.201.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The board received a petition for rule making requesting the placement of carisoprodol in schedule IV of the Uniform Controlled Substances Act. Upon review of the petition and supporting data, the board determined that placement of the substance in schedule IV will limit abuse of the drug.
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: The Drug Enforcement Administration is responsible for the placement of drugs in the Controlled Substances Act at the federal level. The Board of Pharmacy also has the authority to add, delete or reschedule drugs listed in the state Uniform Controlled Substances Act. The Board of Pharmacy will invite representatives of the Drug Enforcement Administration to participate in stakeholder meetings.
Process for Developing New Rule: Collaborative rule making.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Lisa Salmi, Board of Pharmacy, P.O. Box 47863, Olympia, WA 98504-7863, phone (360) 236-4828, fax (360) 586-4359, e-mail Lisa.Salmi@doh.wa.gov. Information on public meetings can be obtained from Lisa Salmi, Board of Pharmacy.
April 4, 2003
for Donald H. Williams